Revelation Biosciences Inc.
13F holders, Q1 2024 (March 31)7holders
$2.73avg. 13F price*
At the end of Q1 2024, 7 institutions reported holding Revelation Biosciences Inc. in their 13F filings. The largest holders were UBS Group AG ($11K), Tower Research Capital LLC (TRC) ($9K) and Osaic Holdings, Inc. ($822).
- Company
- Revelation Biosciences Inc.
- CUSIP
- 76135L507
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $21K |
| Exits | 0 | $0 |
Ownership 7 holders
| UBS Group AG | 0.00% | New | 4,183 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 3,118 | $9K |
| Osaic Holdings, Inc. | 0.00% | New | 300 | $822 |
| Morgan Stanley | 0.00% | New | 5 | $14 |
| Wells Fargo & Company | 0.00% | New | 3 | $8 |
| POM Investment Strategies, LLC | 0.00% | New | 1 | $3 |
| Royal Bank of Canada | 0.00% | New | 36 | $0 |
"% of holder's portfolio" is REVELATION BIOSCIENCES INC's weight in each manager's 13F, not the share of Revelation Biosciences Inc. the manager owns.